Bio Pro Classes:

Tuesday, 17 May 2016 - Wednesday, 29 Jun 2016
Category: Bio Pro Classes

Monday, 25 Jul 2016 - Tuesday, 26 Jul 2016
Category: Bio Pro Classes

Monday, 01 Aug 2016 - Tuesday, 02 Aug 2016
Category: Bio Pro Classes

Thursday, 04 Aug 2016
Category: Bio Pro Classes

Monday, 08 Aug 2016 - Tuesday, 09 Aug 2016
Category: Bio Pro Classes

Thursday, 11 Aug 2016
Category: Bio Pro Classes

Event Registration Cart

Your cart is empty.

 SBIR 101: How to create a competitive SBIR grant application.


Dr FarellThis is a must attend event for any entrepreneur trying to pursue SBIR and other forms of government grant funding. Dr. David Farrell will share decades of experience successfully soliciting federal grants (SBIR, STTR, etc.) from the federal government. Unlike other seminars and workshops, Dr. Farrell takes a hands on approach. From teaching you the history of the programs, to actually logging onto the relevant sites and completing registration forms, participants complete the practical steps necessary to jumpstart their submissions.


Dr. Farrell's workshop will cover the broadest spectrum of federal programs, including SBIR/STTR programs for the National Science Foundation (NSF), United States Department of Agriculture (USDA), and the Environmental Protection Agency (EPA), with an emphasis on the National Institutes of Health (NIH). In addition, the huge Department of Defense budget will also be explored, including a few little-known pots of money--including: the Congressionally Directed Medical Research Programs (CDMRP), Air Force, Defense Advanced Research Projects Agency (DARPA), Navy, Defense Threat Reduction Agency (DTRA), and Army SBIR/STTR programs and other non-SBIR contract programs.


This interactive session will include attendees downloading onto their own laptops each of the subsections of the application forms while Dr. Farrell explains proven strategies for creating competitive applications. This class is focused on overcoming the barriers standing between you and a funded grant.


News Flash

  • OHSU's HIV researcher wins more than $14 million

    Lynne Terry, Oregonian

    Federal officials have given $42 million to top HIV researchers, including Dr. Louis Picker of Oregon Health & Science University.

    Picker has developed one of the most promising HIV vaccines in the country. He'll get a little over a third of the grant from the National Institutes of Health. The same amount will go to Dr. Dan Barouch of Harvard Medical School. Barouch has a promising vaccine that uses a different approach. Six other scientists will share the rest of the money by performing analyses for the two researchers.

    The five-year grant will give Picker and Barouch time to figure out how their approaches to a preventative vaccine are working and then to combine them in hopes of finding a cure.

    Picker said he's relieved to get the grant funded.

    "All of my grants from the past five years are ending so I had to work really hard to renew them," Picker said. "The mission is accomplished. We can keep the USS Enterprise on course for another five-year mission."

    Picker's vaccine eliminated the virus that causes AIDS from 50 to 60 percent of monkeys who's been infected. His approach involves using a herpes virus, cytomegalovirus, to train the immune system to fight HIV so that when cells get infected it attacks. Barouch, who's had about the same success rate in monkeys, relies on antibodies to clear the virus.

    It only takes one potent virus to set up shop in the body. The idea is that Barouch's vaccine could limit the number of infected cells and that Picker's approach could clear out the rest.

    "Stopping HIV may require a combination of vaccine approaches to get full protection," Picker said.

    First, Picker and Barouch have to figure out how their approaches work. Barouch will look at the antibodies and Picker will study killer T cells. Their work on monkeys and the analyses by the other scientists should give them a wider understanding of the science behind the vaccines.

    Picker plans the first human trial with his vaccine next year. The first phase will focus on safety. Barouch is now conducting his second safety trial with his approach. After that comes trials that look at how effective the vaccines are.

Bioscience News

  • The BIO Latin America Conference, happening October 26-28 in São Paulo, Brazil, is the ideal venue to explore the innovation and partnering opportunities in Latin America’s rapidly-growing life science industry. The conference will bring together more than 600 leaders, executives, researchers and investors from around the world to discuss trends and innovations, navigate industry challenges, attend company presentations, conduct face-to-face partnering meetings and learn more about investment opportunities within this emerging Latin American market. The conference will feature Read More >

  • Earlier this year, Inside the Beltway publications, other news outlets and activists wrote about the supposed inevitability of additional states enacting legislation in 2016 requiring the labeling of food containing genetically engineered (GE) ingredients. Almost halfway into the year – and after most state legislatures have adjourned – no state has adopted a GMO labeling bill this year.  In fact, no state has adopted mandatory GMO labeling legislation in more than two years.  As a Read More >

  • Earlier this week, we learned a welcome piece of good news in the ongoing Zika epidemic. Biotechnology companies have been stepping up to the plate to develop technologies to fight back against the virus, and now the first potential vaccine for the virus has received FDA approval to begin clinical trials. As reported in the Washington Post: Pennsylvania vaccine maker Inovio Pharmaceuticals and South Korea’s GeneOne Life Sciences said Monday that they had received approval Read More >

joomla social media module

Underwriting Sponsors

Sustaining Sponsors

Principal Sponsors

Home | Bio in Oregon | BioPro Training | Events | Sponsors | Member Resources | News | About Us

Oregon Bioscience Association Copyright © 2016. All Rights Reserved.